Libd Lieber Institute For Brain Development

The Claypool Laboratory, part of the Department of Physiology at Johns Hopkins University School of Medicine, is dedicated to understanding mitochondrial phospholipid metabolism and its implications for human health and disease. This collaborative team of scientists emphasizes a welcoming and inclusive environment, fostering diverse perspectives that enhance both community and research quality. Generated from the website

Ashvattha Therapeutics is a clinical-stage biopharmaceutical company based in Baltimore, MD, specializing in the development of precision nanomedicines to address unmet medical needs in ophthalmology, neurology, and inflammatory diseases. Their innovative hydroxyl dendrimer HD technology enables the creation of targeted nanomedicines that selectively target activated cells in regions of inflammation, redefining precision medicine and offering a new standard of care. With a focus on traversing tissue barriers, Ashvattha Therapeutics aims to treat diseases with unprecedented precision by developing nanomedicines that are selectively taken up by inflamed tissues. Their pipeline includes potential treatments for ophthalmic conditions, such as wet age-related macular degeneration (AMD) and diabetic macular edema (DME), as well as neuroinflammation and other inflammatory diseases. Through their cutting-edge approach, Ashvattha Therapeutics is dedicated to advancing the field of precision medicine and improving patient outcomes.Generated from the website

The Lutsenko Lab, located at Johns Hopkins University School of Medicine Department of Physiology, is dedicated to studying the molecular mechanisms of copper homeostasis in both healthy and diseased cells. With a focus on understanding copper regulation at the cellular level, the lab conducts cutting-edge research to uncover insights into the role of copper in various physiological and pathological processes. Generated from their website's infomation